Bio-IT World Venture, Innovation & Partnering Conference Returns to Boston April 3, 2025 with Expanded AI Focus

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Participants to Enjoy Access to 24th Annual Bio-IT World Conference & Expo, Running Concurrently April 2-4

BOSTON, Feb. 13, 2025 /PRNewswire/ — Cambridge Healthtech Institute, which produces the annual Bio-IT World Conference & Expo (Bio-IT World 2025), today announced that this global event, which highlights innovative collaborations between biotech and IT leaders, will also feature an exclusive investor conference.

The second annual Bio-IT World Venture, Innovation & Partnering Conference, taking place April 3 in Boston, will bring together 200+ venture capitalists, private equity professionals, bankers, government partners, and entrepreneurs who are advancing the growth of the TechBio, biotech, drug discovery and healthcare sectors.

Content will focus on all stages and types of investments and partnerships, including incubation, venture capital, private equity, and bank investments, with insights from 5AM Ventures, Bain Capital, Flagship Pioneering, F-Prime Capital, HSBC, Norwest Venture Partners, Sanofi Ventures, Third Rock Ventures, and more.

“With the recent upswing in biotech venture funding, this second annual event is particularly timely. This year, we will help investors to capitalize on the breakthroughs ahead by sharing how AI, quantum computing and other advanced platforms are reshaping drug discovery. Leaders from such companies as Google, Psivant Therapeutics, Novo Nordisk, and Qubit Pharmaceuticals will share important perspectives,” said Eileen Murphy, Conference Producer.

Additional highlights will include:

  • A featured presentation by Steve Pagliuca, Chairman, CEO, and Founder, PagsGroup, on Boston’s Pioneering Investments in Technology and Drug Discovery
  • A fireside chat with Derek Lowe, Ph.D., Director, Chemical Biology & Therapeutics, Novartis BioMedical Research, on Investing Beyond the Molecule: The Future of Drug Discovery. John J. Keilty, Venture Partner, Third Rock Ventures, will interview him.
  • Insights from leading women in the vanguard of biotech and investments, such as Joanne L. Viney, Ph.D., Co-founder, President, and CEO, Seismic Therapeutic and Kimberly Nearing, M.S., Venture Partner, Investment Team, BVCF Management Ltd.
  • Bio-IT World Venture, Innovation & Partnering registration information is available here

Media and analysts can request passes here

About Cambridge VIP
Cambridge VIP – Venture, Innovation & Partnering conferences unite senior-level investors, corporate executives, entrepreneurs, and startup leaders from diverse sectors. These exclusive gatherings feature engaging industry panels and fireside chats, fostering meaningful networking and interactions. Join us at these innovative conferences to gain strategic insights, candid perspectives, and valuable business recommendations in your area of interest. Discover who’s investing, track funding activities, and witness the commercialization of emerging technologies solving real-world challenges. 

About Bio-IT World Conference & Expo
For over 20 years, Bio-IT World Conference & Expo has been the premier global event showcasing technologies and analytic approaches that solve problems, accelerate science, and drive the future of precision medicine. By uniting a community of experts in life sciences, pharmaceuticals, clinical research, healthcare, informatics, and technology, the event pushes the boundaries of biomedical research, drug discovery and development, and patient outcomes. The program features inspiring plenary keynotes, 200+ educational and technical presentations, interactive panels, hands-on symposia, technical workshops, unparalleled networking opportunities, and an exhibit hall showcasing cutting-edge technologies and solutions. Attendees are invited to engage in transformative conversations on the latest advancements in digital and data transformations; AI; generative AI; machine learning (ML); real-world data strategies; pilot programs; new product results; and biotech investment trends.

View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-it-world-venture-innovation–partnering-conference-returns-to-boston-april-3-2025-with-expanded-ai-focus-302376064.html

SOURCE Bio-IT World Conference & Expo

Staff

Recent Posts

Medexus Schedules First Fiscal Quarter 2026 Conference Call

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - August 5, 2025) - Medexus Pharmaceuticals (TSX: MDP)…

2 hours ago

Medtronic to announce financial results for its first quarter of fiscal year 2026

GALWAY, Ireland, Aug. 5, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in…

2 hours ago

Cryoport Reports Second Quarter 2025 Financial Results

Second quarter revenue increased 14% year-over-year to $45.5 millionCommercial Cell & Gene Therapy revenue increased…

2 hours ago

QuidelOrtho Reports Second Quarter 2025 Financial Results

― Labs revenue grew 4% as reported and 5% in constant currency ―― Adjusted EBITDA…

2 hours ago

Ategenos Secures Foundational U.S. Patent for First SmartPatch Platform Targeting $1T+ Medication Non-Adherence Crisis

Only platform enabling real-time detection and intervention for medication non-adherence at community scale CAMBRIDGE, Mass.,…

2 hours ago

bioMérieux Develops Game Changing Quality Control Solution GENE-UP® PRO HRM

DNA-Based Heat Resistant Mold Test Delivers Deeper Diagnostics in a Fraction of the Time, On-Site…

2 hours ago